ISSN: 0973-7510

E-ISSN: 2581-690X

Case Report | Open Access
Samuel Pecho-Silva1,2, Ana Claudia Navarro-Solsol3,Vicky Panduro-Correa4, Kovy Arteaga-Livias2,4,Alfonso J. Rodriguez-Morales2,5,6 and Kuldeep Dhama7
1Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.
2Universidad Científica del Sur. Lima, Peru.
3Universidad Nacional de Ucayali. Pucallpa, Peru.
4Facultad de Medicina, Universidad Nacional Hermilio Valdizan. Huanuco, Peru.
5Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia.
6Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, 660004, Colombia.
7Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly – 243 122, Uttar Pradesh, India.
J Pure Appl Microbiol. 2020;14(3):1681-1685 | Article Number: 6516 | © The Author(s). 2020
Received: 20/05/2020 | Accepted: 07/07/2020 | Published: 22/07/2020

Cystic fibrosis (CF) is a chronic lung disease with wide distribution worldwide. With the appearance of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), difficulties arise when evaluating, diagnosing, and treating patients with other conditions, including CF. We present the case of a patient with CF who had a definite serological diagnosis, a CT scan suggestive of SARS-CoV-2 infection/COVID-19, and a negative molecular test (RT-PCR), with rapid resolution of symptoms and early discharge. CF/SARS-CoV-2 comorbidity needs to be adequately studied and assessed in the context of the COVID-19 pandemic.


Cystic fibrosis, COVID-19, SARS-CoV-2, Serological tests, pandemic, Peru, Latin America

Article Metrics

Article View: 3035

Share This Article

© The Author(s) 2020. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.